VNDA icon

Vanda Pharmaceuticals
VNDA

Overview Fund Activity

148 hedge funds and large institutions have $246M invested in Vanda Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 44 increasing their positions, 46 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
+4
Holders Change %
+2.78%
% of All Funds
2.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
44
Reduced
46
Closed
34
Calls
$1.23M
Puts
$2.04M
Net Calls
-$812K
Net Calls Change
-$529K

Top Buyers

1
Schroder Investment Management Group
1
Schroder Investment Management Group
United Kingdom
$6.53M
2
KAM
2
Krensavage Asset Management
New York
$3.74M
3
NCM
3
Nantahala Capital Management
Connecticut
$9M
4
TCM
4
Tang Capital Management
California
$12.2M
5
BCM
5
BML Capital Management
Indiana
$2.25M

Top Sellers

1
Bank of America
1
Bank of America
North Carolina
$437K
2
D.E. Shaw & Co
2
D.E. Shaw & Co
New York
$3.91M
3
Morgan Stanley
3
Morgan Stanley
New York
$2.81M
4
Citadel Advisors
4
Citadel Advisors
Florida
$833K
5
Assenagon Asset Management
5
Assenagon Asset Management
Luxembourg
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
HFS
176
Hantz Financial Services
Michigan
– -$6K -1,500 Closed
MLICM
177
Metropolitan Life Insurance Company (MetLife)
New York
– -$6.05K -1,471 Closed
ACM
178
Aquatic Capital Management
Illinois
– -$1.23K -300 Closed
C
179
Covestor
United Kingdom
– -$1K -286 Closed
First Manhattan
180
First Manhattan
New York
– -$411 -100 Closed
AWM
181
Avior Wealth Management
Nebraska
– -$41 -10 Closed
4 5 6 7
8